MoneyWorks4Me

The sales slipped to Rs. 1163.90 millions for the June 2022 quarter as against Rs. 1275.00 millions during the year-ago period.Profit saw a slight increase of 15.93%to Rs. 632.40  millions from Rs. 545.50 millions.OP of the company witnessed a marginal growth to 810.80 millions from 756.40 millions in the same quarter last year.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202206 202106 % Var 202206 202106 % Var 202203 202103 % Var
Sales 1163.90 1275.00 -8.71 1163.90 1275.00 -8.71 5280.60 4826.80 9.40
Other Income 349.70 193.30 80.91 349.70 193.30 80.91 565.50 186.20 203.71
PBIDT 810.80 756.40 7.19 810.80 756.40 7.19 2761.70 2325.50 18.76
Interest 0.10 0.30 -66.67 0.10 0.30 -66.67 0.90 1.70 -47.06
PBDT 810.70 756.10 7.22 810.70 756.10 7.22 2760.80 2323.80 18.81
Depreciation 63.70 62.00 2.74 63.70 62.00 2.74 257.70 224.40 14.84
PBT 747.00 694.10 7.62 747.00 694.10 7.62 2503.10 2099.40 19.23
TAX 114.60 148.60 -22.88 114.60 148.60 -22.88 624.40 537.10 16.25
Deferred Tax -28.00 2.30 -1317.39 -28.00 2.30 -1317.39 8.20 -11.70 -170.09
PAT 632.40 545.50 15.93 632.40 545.50 15.93 1878.70 1562.30 20.25
Equity 151.60 151.30 0.20 151.60 151.30 0.20 151.60 151.30 0.20
PBIDTM(%) 69.66 59.33 17.42 69.66 59.33 17.42 52.30 48.18 8.55
Peers
Company Name CMP
Sun Pharma. Inds. 1853.00
Dr. Reddys Labs. 1200.40
Cipla 1404.00
Lupin 2098.00
Zydus Lifesciences 1180.00
View more..